AI Article Synopsis
- * It analyzed 239 surgical cases and assessed biomarkers like SII, SIRI, PLR, and NLR, concluding that SIRI had the highest diagnostic performance with an AUC of 0.77 and a sensitivity increase when combined with cytological analysis.
- * The findings suggest that inflammatory biomarkers could enhance the diagnostic process and treatment decisions for challenging cases of salivary gland tumors.
Article Abstract
Background: This study aimed to evaluate the diagnostic performance of serum inflammatory biomarkers in salivary gland tumors with dubious results following cytological analysis.
Methods: A retrospective analysis of 239 cases following surgery between January 2011 and June 2022 was performed. Receiver Operating Characteristic curves were drawn and areas under the curves were computed to evaluate the diagnostic performance of the inflammatory biomarkers (SII, SIRI, PLR, and NLR). Optimal cut-offs for each marker were determined by maximizing the Youden index.
Results: Analysis showed that among the major biomarkers examined, SIRI performed an AUC of 0.77. The best SIRI cut-off was 0.94 with an accuracy of 79.9%. The accuracy, sensitivity, and specificity of cytological analysis were 77.8%, 59.6%, and 90.7% respectively. By combining SIRI with cytological analysis we demonstrated an increase in sensitivity to 82.8%.
Conclusions: Inflammatory biomarkers could be evaluated to support the diagnosis and treatment of salivary gland tumors in difficult cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hed.27528 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!